
Multinational biopharmaceutical company.
Sr Associate Finance at Amgen
About the role
Career Category
Finance
Job Description
As a Sr Associate in Finance at Amgen, you'll provide crucial support in financial management including financial reporting, budgeting, forecasting, and analysis. You'll work closely with the finance manager and other team members to help make informed financial decisions. This role will support Amgen's Global Supply Chain department. Key responsibilities include:
- Financial planning and analysis of headcount and operating expenses, supporting the quarterly forecast, annual budgeting, long range planning, quarterly close processes, and financial dashboards in visual analytics tools like PowerBI and Tableau.
- Data analysis and management of client's financial submissions into Amgen's financial systems (Hyperion/Anaplan)
- Provide critical financial insights into new and continuous operational improvement opportunities
- Supporting finance leadership and functional teams with ad hoc requests and special projects
.
Required skills
Financial analysis
Budgeting
Forecasting
Reporting
Data analysis
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
More open roles at Amgen

Manager, AI Value Realization
Amgen · Portugal - Lisbon

Senior Specialty Representative - Bone Health - Chattanooga, TN
Amgen · US - Tennessee - Chattanooga

Medical Science Liaison; MD/DC/WV/DE; U.S. Medical, Rare Disease-GPA/MPA & Sjogren’s Disease
Amgen · US - Maryland - Baltimore; US - Delaware - Dover; US - West Virginia - Charleston; US - Washington D.C.

Specialty Representative/Senior Specialty Rep - PCS Team - Cape Coral, FL
Amgen · US - Florida - Cape Coral

QA Sr Manager External Supply Quality (ESQ) - Supplier Quality Management
Amgen · US - North Carolina - Charlotte; US - California - Los Angeles; US - Massachusetts - Boston; US - Rhode Island - Providence
Similar jobs

Program Cost Controls Finance Lead (P4) *HYBRID*
Collins Aerospace (RTX) · US-MA-TEWKSBURY-TB4 ~ 836 North St ~ INNOVATION BLDG

Sr. Mgr. SBU Technical Accounting
Collins Aerospace (RTX) · US-MA-TEWKSBURY-TB3 ~ 50 Apple Hill Dr ~ CONCORD BLDG, Tewksbury Tb3 300 Concord

AMRAAM Cost Controls/Investments - Current Security Clearance Required
Collins Aerospace (RTX) · US-AZ-TUCSON-848 ~ 1151 E Hermans Rd ~ BLDG 848

Principal Program Cost Controls Specialist - On-Site
RTX (Raytheon) · US-AZ-TUCSON-848 ~ 1151 E Hermans Rd ~ BLDG 848

Principal Financial Analyst, Program Cost Controls
RTX (Raytheon) · US-TX-PLANO-465 ~ 465 Independence Pkwy ~ INDEPENDENCE
About Amgen

Amgen
PublicA biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10,001+
Employees
Thousand Oaks
Headquarters
$138B
Valuation
Reviews
24 reviews
3.6
24 reviews
Work-life balance
3.2
Compensation
3.5
Culture
3.1
Career
2.8
Management
3.4
65%
Recommend to a friend
Pros
Excellent benefits and health benefits
Good pay and compensation
Supportive management and leadership
Cons
Limited career growth and promotion opportunities
Work-life balance challenges and long hours
Bureaucratic processes
Salary Ranges
1,002 data points
Mid/L4
Senior/L5
Mid/L4 · Business Performance Manager
3 reports
$140,000
total per year
Base
$121,872
Stock
-
Bonus
-
$140,000
$140,000
Interview experience
5 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Offer rate
40%
Experience
Positive 20%
Neutral 80%
Negative 0%
Interview process
1
Application Review
2
Recruiter Screen
3
Hiring Manager Interview
4
Technical/Case Interview
5
Final Round/Panel Interview
6
Offer
Common questions
Technical Knowledge
Behavioral/STAR
Past Experience
Case Study
Culture Fit
Latest updates
FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
HN
·
1w ago
·
1
·
1
Amgen posts Q1 results April 30; anyone can hear the webcast live - Stock Titan
Stock Titan
News
·
2w ago
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS - Yahoo Finance
Yahoo Finance
News
·
2w ago
Amgen’s Chief Technology Officer Dr David Reese to retire - European Pharmaceutical Review
European Pharmaceutical Review
News
·
2w ago